Welldoc’s BlueStar® further expands use of digital tool for diabetes care within leading academic medical center
Columbia, MD June 11, 2020 – Welldoc®, revolutionizing digital health with the first FDA-cleared Software as a Medical Device (SaMD) for diabetes, today announced the expansion of an agreement with Mass General …
Welldoc Receives FDA Clearance for Long-Acting Insulin Support for Award-Winning Digital Health Solution BlueStar®
Marks 8th FDA clearance for BlueStar, the only reimbursable Software as a Medical Device for diabetes that integrates with all of a patient’s existing devices Columbia, MD – June 3, 2020 – …
Welldoc Announces Collaboration with Dexcom to Enhance the Value of BlueStar® with the Dexcom G6® CGM System
Columbia, MD – March 11, 2020 – Welldoc, a leading digital health company, announced today a collaboration with Dexcom, the global leader in continuous glucose monitoring (CGM) systems for people with diabetes. …
Welldoc and Redox Partner to Optimize Provider Interaction with Chronic Disease Management Platform
Partnership ensures bidirectional integration with EHRs and insights available at the point of care MADISON, WI—February 25, 2020—Welldoc, a leading digital health company revolutionizing chronic disease management, announced today its strategic partnership …
Welldoc Submits 510(k) for Long-Acting Insulin Support for Their Award-winning Digital Health Solution BlueStar®
This is Welldoc’s 8th 510(k) filing to the U.S. Food and Drug Administration Columbia, MD – January 16, 2020 – Welldoc, a leading digital health company, announced today the filing of a …
Express Scripts Improves Patient Access to Digital Health Solutions
Future-focused formulary for digital health, medicine and therapeutics will allow employers and health plans to effectively manage a fast-growing segment of health care while improving access for patients. ST. LOUIS, December 12, …